TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
TELA Insider Transactions (Form 4)
67
29 Form 4 filings on record, the earliest from Oct 24, 2024, newest first.
TELA Bio, Inc. (TELA) had 11 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for TELA runs to 29 Form 4 filings, the earliest from 2024-10-24. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying TELA stock?
2 insider purchases of TELA were filed in the last 90 days, totaling $19K.
How many insiders are selling TELA stock?
No insider sales of TELA were filed in the last 90 days.
Where can I see TELA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks TELA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow TELA insider buys?
Create a free InsiderAlpha account and press Watch on this page to add TELA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
